ABSTRACT
) with essential hypertension. All patients were put on a high-sodium diet (200 mmol NaCl per day) for one week after a week on a low-sodium diet (20 mmol NaCl per day). Sodium sensitivity (SS) was defi ned as a 10-mmHg increase in the mean

INTRODUCTION
With a decrease in extracellular volume, the binding of ATII to its receptors on vascular smooth muscle cells decreases due to previous ATII bindings to the same receptors, which leads to lower blood pressure levels. At the same time, the number of ATII receptors is increased on suprarenal glands, which causes increased aldosterone production. The overall result is sodium retention without a significant increase in blood pressure. It has been reported that the modulation of the adrenal and vascular responses to ATII is non-adequate in 30-50% of hypertensive patients, who are then considered "non-modulators" 1 . Most patients with essential hypertension are not characterized as expected (i.e., higher perfusion pressure in juxta-glomerular cells and higher blood volume), with low, inhibited plasma-renin activity (PRA) but are instead characterized rather withby normal or even high PRA values. According to Sealey and co., this discrepancy is caused by nephron heterogeneity, with a special subgroup of ischaemic nephrons that contribute to high PRA values 2 . The third model of "non-modulation" was proposed by Williams and Holenberg 3 . Healthy individuals modulate the response of target tissues to ATII according to their sodium intake. Decreased sodium intake is followed by an increase in aldosterone production and a decrease in vascular response. During sodium loading, the suprarenal response is decreased, and the vascular response is increased, especially in the kidney circulation, which stimulates sodium excretion from the kidney. Williams and Holenberg reported that 50% of patients with essential hypertension with normal and/or high PRA values are characterized with disorders of ATII modulation on target tissues according to sodium intake and are considered "non-modulators". Regulatory disorders characterized by fixed ATII concentrations in target tissues lead to increased aldosterone production during sodium restriction and increased blood flow in the kidney circulation during sodium loading. The confirmation of this hypothesis was achieved by the correction of abnormalities with ACE inhibitor administration.
Numerous mechanisms of pathogenesis in hypertensive patients with low PRA values have been described 4 
.
In the majority of patients, low PRA values are followed by normal (not low, as expected) aldosterone values, which are explained by increased sensitivity of the suprarenal glands to ATII. Several studies have shown low rates of cardiovascular complications in patients with essential hypertension and low PRA values 5, 6 . Other studies have revealed that diuretic therapy is more efficient in hypertensive patients with low PRA values than in hypertensive patients with high PRA values. In the former group, diuretic therapy leads to smaller increases in PRA values, with smaller vascular responses and aldosterone production, which cause decreases in plasma volume and blood pressure 7 . In "bipolar vasoconstriction-volume analysis", the vasoconstriction of the kidney's arterioles is caused by ATII actions, which are responsible for hypertension in patients with high PRA values, and increased plasma volume, which is responsible for hypertension in patients with low PRA values 8, 9 . It should be emphasized that most clinicians and research workers rely on PRA blood values, but the tissue concentrations might be different, and the pathogenesis of the disorder might be even more complicated.
AIM OF THE STUDY
The aim of this study was to assess PRA and aldosterone values during different regimes of salt intake in patients with essential hypertension.
PATIENTS AND METHODS
The study group consisted of 50 untreated patients (27 women and 23 men; average age 42±9,2 yrs.; average BMI 27,91±4,6 kg/m 2 ) with essential hypertension. The causes of secondary hypertension were excluded with standardized endocrinological investigation, and antihypertensive therapy was stopped two weeks before the study. A finding of fixed elevated blood pressure ³160/95 mmHg without therapy over at least four days was considered as stable hypertension. Borderline hypertension was defined as a temporary increase in diastolic pressure ³90 mmHg during three different measurements. Hypertension was classified according to the Seventh Joint Committee for the detection, evaluation and treatment of hypertension. The study was conducted in hospital. All patients were put on a high-sodium diet (200 mmol NaCl per day) for one week after a week on a low-sodium diet (20 mmol NaCl per day). Sodium sensitivity was defined as a 10-mmHg increase in mean blood pressure at the end of the high-vs. the lowsodium diet. The sodium-sensitive group consisted of 26 patients, and the sodium-insensitive group consisted of 24 patients. The electrolytes in serum and urine and blood pressure were measured on the last day of normal salt intake and on 1 st , 3 rd and 5 th days of the low-and high-sodium diets. All patients had normal sodium and potassium serum concentrations. Sodium intake was controlled by 24-hour urine sampling, and sodium excretion between 100 and 150 mmol/d was considered satisfactory. Calcium intake was standardized and was approximately 817 mg per day. During the 7-day low-sodium diet, sodium intake was balanced to achieve a sodium excretion of 40 mmol per day. During the high-sodium intake, 10 mg of salt (NaCl) was added to each participant's normal food intake. Sodium excretion more than 200 mmol/day was considered satisfactory during the high-sodium diet. Blood samples for aldosterone and PRA determinations were prepared according to standardized procedures. Aldosterone was measured using a Maia-Biodata radioimmunoassay with a normal range of 0.03324-0.4155 nmol/l in the lying position, with an interassay CV=8.8% and an intraassay CV=7.6%. PRA was measured using a Sorin Biomedica radioimmuno-assay, with a normal range of 0.1542-2.159 nmol/l/h in the lying position and a normal range of 1.1565-4.3947 nmol/l/h in the supine position, with an interassay CV=11.5% and an intraassay CV=9.9%. Blood pressure was measured daily at 8 AM (before breakfast) and at 6 PM with the same sphygmomanometer. Blood pressure value was considered the average value of two measurements on the non-dominant arm after 5 minutes of rest. The criteria for hypertension were diastolic pressure ³ 90 mmHg, (Korotkoff phase V) and/ or systolic pressure ³ 140 mmHg without therapy. Patients were divided to a salt-sensitive and a salt-resistant group according to the change in mean arterial pressure during the low-and high-salt diets (20 vs. 200 mmol/day). Average values of mean arterial pressure were used for the determinations of salt sensitivity. Increases of more than 10 mmHg in the mean arterial pressure of were considered salt sensitivity. The RMANOVA test, correlation analysis methods, and the unpaired and paired t-tests were used for statistical analyses.
RESULTS
PRA and aldosterone levels were determined in 12 patients. Two blood samples were obtained in morning hours (in rest and effort) on normal salt intake and on the 5 th days of the low-and high-salt diets. After analysing the data, we divided patients into a salt-sensitive group (with low basal PRA values) and a salt-resistant group (with high basal PRA values).
Statistical analysis revealed that PRA values in the saltsensitive group during rest were significantly lower compared with the salt-resistant group during all regimes of salt intake (F=10,56, p=0,0012).
It was also shown that salt loading in salt-sensitive patients caused significant decreases in PRA values (in rest and effort) in comparison with values during the low-salt intake regime. (rest: t=4,49, p<0,001; effort: t=3,45, p<0,01). PRA values in the salt-resistant group did not vary significantly during the different regimes of salt intake (Table 1) .
Aldosterone values followed the pattern of PRA values and were significantly different in the salt-sensitive group (in rest and effort) between the high-and low-salt intake regimes (rest: 3,53, p<0,01; effort: t=2,37, p<0,05).
Correlation analysis of PRA and aldosterone values with calcium parameters revealed positive correlations between PRA, aldosterone and ionized calcium (PRA: r=0,62, r 2 =0,38, p=0,034, aldosterone: r=0,51; r 2 =0,26; p=0,041) in salt-sensitive patients during the high-salt intake regime. No significant correlations were found between these parameters during the normal and low-salt intake regimes.
A negative correlation between PRA and urinary calcium was found in the high-salt intake regime in salt-sensitive patients (r=-0,41; r 2 =0,17; p=0,049). Aldosterone was not significantly correlated with urinary calcium.
Total blood calcium was not significantly correlated with PRA and aldosterone during all three regimes. We also found negative correlations of PRA (r=0,53, r 2 =0,28, p=0,02) and aldosterone (r=-0,47, r 2 =0,22, p=0,035) values with mean arterial pressure regarding salt sensitivity during the high-salt intake regime.
DISSCUSION
Kawasaki and co-workers first divided essential hypertension into salt-sensitive and salt-resistant types according to the response of blood pressure to salt loading 10 . Data presented in the literature showed that salt sensitivity in established essential hypertension occurs in between 30 and 60% of cases 11 . In borderline hypertension, salt sensitivity occurs in 29% of cases, while in the normotensive population, salt sensitivity occurs in 16-25% of cases. The prevalence of salt-sensitive hypertension depends on the defining criteria. For the definition of salt sensitivity, some authors use changes in salt intake, and others use the response of blood pressure to the ratio of the increase in volume due to sodium intake and the decrease due to diuretic administration 12, 13 . Different sodium intake protocols are also used (20 and 220 mmol/d or 70 and 370 mmol/d). It is important to emphasize that changes in blood pressure in response to sodium intake follow a normal distribution curve; therefore, the division is arbitrary.
In several studies, Resnick and co-workers showed correlations between calcium metabolism disturbances, salt sensitivity, PRA and aldosterone system and calcium-regulating hormones in hypertensive patients 14, 15 . The results of these studies showed the characteristic metabolic and hormonal profiles of salt-sensitive patients (low basal PRA values, higher PTH and 1,25-(OH) 2 -D values, lower calcitonin values, low ionized calcium and higher serum magnesium values), while the salt-resistant group was characterized by reversed metabolic and hormonal profiles. The first studies that investigated the pathogenesis of hypertension explained the increase in the intracellular calcium concentration (and the increase in vascular resistance) by the primary disturbance in membrane ion transport or the actions of some circulating factors on membrane transport 16 . Resnick showed that PRA and calcium-regulated hormones co-ordinate the modulation of sodium's and calcium's effects on blood pressure by influencing membrane ion transport and intracellular ion concentrations. The authors stated that salt and calcium sensitivities could be partially explained by disturbances in metabolic and hormonal parameters 17 .
Other authors confirmed the presence of low PRA values in salt-sensitive normotensive and hypertensive individuals 18 . with the salt-resistant group during different regimes of salt intake. Salt loading in the salt-sensitive group caused significant decreases in PRA values, both in rest and effort, in comparison with those values during low sodium intake. Aldosterone values in our study followed the pattern of PRA values during all diet regimes. We also investigated the correlations of different parameters. We found positive correlations between PRA values, aldosterone and ionized calcium and a negative correlation between PRA values and urinary calcium during the high-salt intake regime. Our study also revealed negative correlations between PRA and aldosterone values and mean arterial pressure regarding salt sensitivity during the high-salt intake regime. These results are similar to those of Resnick's group and some other authors, who found significantly low PRA values in salt-sensitive hypertensive and normotensive persons and higher PRA values in salt-resistant individuals 19, 20 . Resnick especially emphasized that low PRA values and ionized calcium could be excellent predictors of the hypotensive effect of calcium supplementation in hypertensive patients.
Some studies have shown that salt-resistant hypertensive patients have higher PRA and aldosterone serum values in comparison with salt-sensitive persons during a low-salt intake regime 21, 22 . Our study confirmed these findings, although we did not detect significant correlations. Significant decreases in these parameters in the salt-sensitive group during salt loading could partially explain better possibilities for the excretion of loaded sodium. Other authors did not find significant differences in basal PRA and aldosterone values in normotensive, salt-sensitive and salt-resistant hypertensive persons during different salt intake regimes 23, 24 . Numerous authors found negative correlations between decreased blood pressure during salt restriction and increased PRA values 25 . The degree of renin system reactivity could predict the response of blood pressure to salt restriction. Cappuccio administered saralasin (a competitive AII inhibitor) to hypertensive patients on the 5 th day of a low-salt intake regime. The decrease in blood pressure caused by saralasin administration was negatively correlated with the decreased blood pressure caused by sodium restriction. Patients with the most prominent decrease in blood pressure during salt restriction had the smallest decrease of blood pressure during saralasin administration, demonstrating the significance of the renin-angiotensin-aldosterone response to salt restriction. A special subgroup involves patients with heart failure, where more liberal sodium intake can achieve an adequate suppression of plasma renin levels 26 . Paterna et al., in a randomized clinical trial, showed that sodium restriction to 80 mmol/day significantly increased hospitalization and mortality compared with a sodium intake of 120 mmol/day in patients with compensated heart failure and aggressive diuretic therapy 27 .
CONCLUSION
It is necessary to distinguish investigations on the effects of salt intake on the incidence and values of blood pressure from investigations on salt restriction's effects on blood pressure levels (i.e., a non-pharmacological therapy for hypertension). Research on salt-sensitive parameters seeks details to quantify the already-established correlation. Different factors could play significant roles in the salt sensitivity phenomenon: i.e., higher sodium retention, abnormal supressibility of the RAAS system, abnormal responses of the sympathetic nervous system, differences in vascular reactivity and abnormality in Na-K-ATP enzymes.
